CrestPoint Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $1.81M | Hold |
29,600
| – | – | 1.01% | 24 |
|
|
2017
Q3 | $1.89M | Sell |
29,600
-2,300
| -7% | -$147K | 0.84% | 26 |
|
|
2017
Q2 | $1.78M | Buy |
31,900
+10,000
| +46% | +$557K | 0.83% | 28 |
|
|
2017
Q1 | $1.19M | Buy |
21,900
+1,000
| +5% | +$54.4K | 0.57% | 57 |
|
|
2016
Q4 | $1.22M | Buy |
20,900
+1,000
| +5% | +$58.4K | 0.61% | 50 |
|
|
2016
Q3 | $1.07M | Buy |
19,900
+7,100
| +55% | +$383K | 0.55% | 58 |
|
|
2016
Q2 | $941K | Buy |
12,800
+600
| +5% | +$44.1K | 0.5% | 73 |
|
|
2016
Q1 | $779K | Buy |
12,200
+1,400
| +13% | +$89.4K | 0.42% | 91 |
|
|
2015
Q4 | $743K | Sell |
10,800
-700
| -6% | -$48.2K | 0.42% | 86 |
|
|
2015
Q3 | $681K | Sell |
11,500
-6,400
| -36% | -$379K | 0.39% | 96 |
|
|
2015
Q2 | $1.19M | Buy |
17,900
+400
| +2% | +$26.6K | 0.63% | 49 |
|
|
2015
Q1 | $1.13M | Buy |
17,500
+13,300
| +317% | +$858K | 0.59% | 54 |
|
|
2014
Q4 | $248K | Hold |
4,200
| – | – | 0.13% | 203 |
|
|
2014
Q3 | $215K | Sell |
4,200
-600
| -13% | -$30.7K | 0.13% | 202 |
|
|
2014
Q2 | $233K | Sell |
4,800
-100
| -2% | -$4.85K | 0.14% | 192 |
|
|
2014
Q1 | $255K | Sell |
4,900
-1,100
| -18% | -$57.2K | 0.16% | 184 |
|
|
2013
Q4 | $319K | Buy |
+6,000
| New | +$319K | 0.21% | 157 |
|